Stages | Mean ± SD in group 1A patient | Mean ± SD in group 1B patients | Mean ± SD in group II normal controls |
---|---|---|---|
Baseline B | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 |
Before 2nd dose (C) | 205 ± 613 | 1 ± 4 | 0.00 ± 0.00 |
After 2nd dose (D) | 1181 ± 2912 | 26 ± 49 | 118 ± 397 |
Before 3rd dose (E) | 524 ± 1478 | 40 ± 90 | 225 ± 317 |
After 3rd dose (F) | 8834 ± 14136 | 462 ± 814 | 16906 ± 21301 |
Statistical Significance | p | p | p |
 | B/C > 0.05, BD < 0.05 | B/C > 0.05 B/D > 0.05 | B/C > 0.05 B/D > 0.05 |
 | B/E > 0.05 B/F < 0.01* | B/E > 0.05 B/F < 0.05 | B/E < 0.01* B/F < 0.01* |